Earnings · China A-shares
Chongqing Lummy Pharmaceutical Co., Ltd. Class A (300006) earnings
Chongqing Lummy Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit +33.18% year on year, +17.64% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +26.85% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- +33.18%
- Excl. one-offs YoY
- +17.64%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +13.17% | — |
| 3 days | +26.85% | — |
| 7 days | +16.75% | — |
| 14 days | +51.28% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 1 of 8 reports (average -0.40%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | -¥30.68M | +33.18% | +17.64% | -9.58% | -0.03 | -1.76% | +26.85% | — | — |
| 2026 interim report | 2026-08-21 | -¥23.42M | +25.37% | +20.04% | -7.09% | -0.02 | -1.34% | -5.72% | -7.91% | -2.21% |
| 2026 Q1 report | 2026-04-23 | -¥15.01M | -8.98% | -8.25% | -8.16% | -0.01 | -0.86% | -0.31% | -22.03% | -20.48% |
| 2025 annual report | 2026-03-19 | -¥134.71M | -53.42% | -17.32% | -2.50% | -0.13 | -7.42% | -10.69% | +28.83% | +25.46% |
| 2025 Q3 report | 2025-10-22 | -¥45.92M | -73.82% | +13.05% | -4.06% | -0.04 | -2.48% | -1.93% | +16.95% | +18.29% |
| 2025 interim report | 2025-08-22 | -¥31.38M | -2462.45% | -16.93% | -1.19% | -0.03 | -1.69% | -2.82% | -13.51% | -21.30% |
| 2025 Q1 report | 2025-04-24 | -¥13.78M | -201.08% | -92.25% | +9.54% | -0.01 | -0.74% | -2.40% | +16.77% | +14.49% |
| 2024 annual report | 2025-03-22 | -¥87.80M | -883.55% | -98.34% | -11.17% | -0.08 | -4.31% | -6.18% | -5.65% | -2.63% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
Stock valuations: 300006 · Stock news: 300006
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.